Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GTx has got $1.2m grant from the US Government under the Qualifying Therapeutic Discovery Project Program (QTDP).
Subscribe to our email newsletter
The grant to GTx comprises separate payments of $244,000 for each of five cancer and cancer supportive care research and development programs.
Gtx CEO Mitchell Steiner said that they are pleased to receive this recognition and these funds will help GTx advance their pipeline of clinical and preclinical product candidates.
Gtx is a biopharmaceutical company engaged in discovery, development and commercialisation of small molecules that selectively target hormone pathways for the treatment and prevention of cancer.